🧪HHS Certified Laboratories for Federal Drug Testing Compliance
The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines) using Urine and the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.
Learn More🧪NIH Meeting Notice for Grant Application Review
The Department of Health and Human Services is holding a closed meeting for the National Institute of General Medical Sciences to review grant applications. The meeting, taking place virtually, involves discussions around confidential trade secrets and personal information pertaining to those applications, ensuring privacy and compliance with federal regulations.
Learn More🏥Notice of Meeting
The Department of Health and Human Services announces a virtual meeting of the National Advisory General Medical Sciences Council to discuss programs, grant applications, and other council business. The meeting is open to public participation and aims to address significant topics in biomedical research and funding.
Learn More⛏️Petition for Modification of Mine Safety Standards by MSHA
This notice is a summary of a petition for modification submitted to the Mine Safety and Health Administration (MSHA) by ICG Beckley, LLC.
Learn More🦺New OSHA Compliance Requirements for Acrylonitrile Exposure
The Department of Labor (DOL) is submitting this Occupational Safety & Health Administration (OSHA)-sponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited.
Learn More📜FDA Delays Effective Date for Nonprescription Drug Regulation
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) is delayed until March 21, 2025.
Learn More🏥Extension of Comment Period for Draft Toxicological Profiles
On November 8, 2024, the Agency for Toxic Substances and Disease Registry (ATSDR), within the Department of Health and Human Services (HHS), announced the opening of a docket to obtain comments on drafts of five updated toxicological profiles. This notice extends the comment period to February 13, 2025.
Learn More🚚FMCSA Notice on Driver Exemptions for ICD Patients
FMCSA announces receipt of applications from two individuals for an exemption from the prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) against operation of a commercial motor vehicle (CMV) by persons with a current clinical diagnosis of myocardial infarction, angina pectoris, coronary insufficiency, thrombosis, or any other cardiovascular disease of a variety known to be accompanied by syncope (transient loss of consciousness), dyspnea (shortness of breath), collapse, or congestive heart failure. If granted, the exemptions would enable these individuals with ICDs to operate CMVs in interstate commerce.
Learn More💉CDC ACIP Meeting Notice
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment.
Learn More